Pyrazole compound as well as composition and application thereof

A technology for pyrazoles and compounds, applied in the field of stereoisomers and their prodrug molecules, and the preparation of drugs, which can solve the problems of unclear specific effects and regulatory mechanisms

Active Publication Date: 2010-09-22
GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its specific role and r

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrazole compound as well as composition and application thereof
  • Pyrazole compound as well as composition and application thereof
  • Pyrazole compound as well as composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a compound and application of the compound and the pharmaceutically acceptable salt thereof or a stereo isomer or a prodrug molecule thereof in preparing a medicament for treating or preventing metabolic diseases, wherein the compound has the structural characteristic of a general expression I and is used as a novel fat cell type fatty acid binding protein FABP inhibitor. The compound having the structural characteristic of the general expression I can provide a new selection for the clinical prevention and treatment of the following diseases: 1. type II diabetes, 2. hyperglycemia, 3. hypoglycemia tolerance, 4. insulin resistance, 5. adiposity, 6. lipid turbulence, 7. blood-lipoid imbalance, 8. hyperlipaemia, 9. hypertriglyceridemia, 10. hypercholesterolemia, 11. low high-density protein level, 12. overhigh low-density protein level, 13. atherosclerosis and secondary diseases thereof, 14. hemadostenosis, 15. abdominal obesity, 16. a metabolic syndrome and 17. fatty liver.

Description

technical field The invention belongs to the field of chemical medicine, in particular to pyrazole compounds or their pharmaceutically acceptable stereoisomers and prodrug molecules, pharmaceutical compositions containing such compounds and the use of these compounds or compositions in the preparation of medicines application. Background technique Lipids and lipid signaling pathways play an important role in integrating metabolic and inflammatory responses, which in turn affect the pathogenesis of chronic metabolic diseases, including type 2 diabetes, fatty liver, and atherosclerosis. However, its specific role and regulatory mechanism are not clear. Fatty acid binding proteins (fatty acid binding proteins, FABPs) are members of the lipid-binding protein superfamily. They are soluble proteins with a molecular weight of 14-16 kD and strong affinity for saturated and unsaturated long-chain fatty acids. In the cytoplasm of animals and invertebrates. It is an important fatty ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D231/12C07D405/04C07D417/04C07D409/04A61K31/415A61K31/4155A61K31/427A61P3/10A61P3/08A61P5/50A61P3/04A61P3/06A61P9/10A61P9/08A61P3/00A61P1/16
Inventor 丁克刘秀洁王东业惠晓艳徐爱民吴东海
Owner GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products